Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ABCC5 mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the messenger RNA encoding the ATP-binding cassette sub-family C member 5 (ABCC5) protein, also known as Multidrug Resistance-associated Protein 5 (MRP5). This region contains specific sequences that serve as binding sites for microRNAs (miRNAs) and RNA-binding proteins, which post-transcriptionally regulate ABCC5 expression by influencing mRNA stability and translation efficiency (Source: PubMed, PMID: 25605241). The ABCC5 protein itself is a transmembrane transporter that effluxes cyclic nucleotides and various chemotherapeutic agents, such as thiopurines and fluorouracil, contributing to multidrug resistance in several cancers (Source: UniProt, P33527). Targeting the ABCC5 mRNA 3'UTR with miRNA mimics or antisense oligonucleotides aims to downregulate ABCC5 protein levels, thereby increasing the intracellular concentration of drugs and overcoming resistance (Source: PubMed, PMID: 22430212). This approach is particularly relevant in oncology, where ABCC5 overexpression is linked to poor prognosis and treatment failure in breast, lung, and brain tumors. By modulating this regulatory region, researchers hope to sensitize resistant cancer cells to standard chemotherapy regimens (Source: PubMed, PMID: 25605241).
Binding of microRNA mimics or antisense oligonucleotides to the 3'UTR sequence leads to mRNA degradation or inhibition of translation, thereby reducing the expression of the ABCC5 protein.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family C member 5 mRNA 3' untranslated region (ABCC5 mRNA 3'UTR).